Seeing Is Believing
HCAT is currently covered by 16 analysts with an average price target of $10.75. This is a potential upside of $4.44 (70.36%) from yesterday's end of day stock price of $6.31.
Health Catalyst's activity chart (see below) currently has 88 price targets and 123 ratings on display. The stock rating distribution of HCAT is 65.52% BUY and 34.48% HOLD.
Analysts average stock forecasts to be materialized ratio is 39.53% with an average time for these price targets to be met of 103.12 days.
Highest price target for HCAT is $16, Lowest price target is $8, average price target is $10.75.
Most recent stock forecast was given by SCOTT SCHOENHAUS from KEYBANK on 26-Feb-2024. First documented stock forecast 19-Aug-2019.
Currently out of the existing stock ratings of HCAT, 38 are a BUY (65.52%), 20 are a HOLD (34.48%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
10
$3.69 (58.48%)
16
2 months 6 days ago
0/2 (0%)
$2.28 (29.53%)
Buy
10
$3.69 (58.48%)
11
2 months 9 days ago
3/6 (50%)
$2.22 (28.53%)
70
Buy
11
$4.69 (74.33%)
11
2 months 9 days ago
4/10 (40%)
$3.22 (41.39%)
96
Buy
15
$8.69 (137.72%)
17
2 months 9 days ago
2/9 (22.22%)
$7.22 (92.80%)
1
Buy
14
$7.69 (121.87%)
3 months 6 days ago
0/3 (0%)
$3.7 (35.92%)
What is HCAT (Health Catalyst) average time for price targets to be met?
Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?
Which analyst has the most public recommendations on HCAT (Health Catalyst)?
Which analyst is the currently most bullish on HCAT (Health Catalyst)?
Which analyst is the currently most reserved on HCAT (Health Catalyst)?